Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion type Assertion NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_head.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion description "[We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132), IDH2 (R140 and R172), and c-CBL (exons 8 and 9) in 62 MPN patients (52 essential thrombocythemia (ET), five polycythemia vera (PV), and five primary myelofibrosis (PMF)) negative for both JAK2 (V617F and exon 12) and MPL (exon 10) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_provenance.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion evidence source_evidence_literature NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_provenance.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion SIO_000772 21904853 NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_provenance.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion wasDerivedFrom befree-20150227 NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_provenance.
- NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_assertion wasGeneratedBy ECO_0000203 NP475200.RAfUcrM8HkqBiLF8HBfQMZuovWtpaR1MaQ9I6sDP68pY0130_provenance.